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In Vivo Aortic Valve Thermal Heterogeneity
in Patients With Nonrheumatic Aortic Valve Stenosis
The First In Vivo Experience in Humans
Konstantinos Toutouzas, MD,* Maria Drakopoulou, MD,* Andreas Synetos, MD,*
Eleftherios Tsiamis, MD,* George Agrogiannis, MD,† Nikolaos Kavantzas, MD,†
Eustratios Patsouris, MD,† Dimitris Iliopoulos, MD,‡ Stergios Theodoropoulos, MD,§
Magdi Yacoub, MD,§ Christodoulos Stefanadis, MD*
Athens, Greece; and London, United Kingdom
Objectives We investigated in vivo in aortic valve stenosis (AVS) whether there is: 1) thermal heterogeneity within the valve
leaflets; 2) temperature difference between the leaflets and the ascending aortic wall; and 3) a possible correla-
tion between heat production, inflammation, and neoangiogenesis.
Background Histological studies have demonstrated a potential role of inflammation and neoangiogenesis in AVS.
Methods We examined 96 leaflets scheduled for aortic valve replacement. Twenty-five patients had AVS, and 7 had aortic
valve insufficiency (AVI). Temperature measurements were performed right before hypothermic cardioplegia.
Temperature difference (T) was assigned as the mean temperature of each leaflet minus the temperature of
the aortic wall. Histological, immunohistological analysis, and vascular endothelial growth factor (VEGF) immu-
noreactivity was performed.
Results Significant thermal heterogeneity was recorded within the leaflets of AVS, compared with AVI (1.52  1.35°C
vs. 0.13  0.11°C, p  0.01). In AVS T was greater in all leaflets compared with the AVI group (p  0.01).
Leaflets of AVS had increased inflammatory cell infiltration, calcium deposit, and anti-VEGF expression com-
pared with AVI (p  0.01).
Conclusions Thermal heterogeneity is increased in AVS and correlates with inflammatory mononuclear cell infiltration,
expression of pro-inflammatory cytokines and neoangiogenic factors. (J Am Coll Cardiol 2008;52:758–63)
© 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.04.057i
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(he prevalence of aortic valve stenosis (AVS) increases with
ge and is the most common reason for valve replacement
1–4). Several studies have shown that local infiltration of
nflammatory cells within leaflets of AVS is a prominent
eature of aortic valve calcification. In addition to inflam-
ation, neoangiogenesis has been described in severe AVS,
imilarly to atherosclerotic lesions (3,5).
See page 764
We postulated that the inflammatory activation within
he aortic valves might generate heat (6,7). We investigated
rom the *First Department of Cardiology, Hippokration Hospital, Athens and the
Department of Pathology, Athens Medical School, Athens, Greece; ‡Department of
ardiosurgery, Iatriko Kentro, Marousi, Athens, Greece; §Department of Cardio-
urgery, Iasso General Hospital, Athens, Greece; and the Imperial College Heart
cience Center, Harefield Hospital, London, United Kingdom.a
Manuscript received January 30, 2008; revised manuscript received March 19,
008, accepted April 5, 2008.n vivo in patients with AVS whether there is: 1) thermal
eterogeneity within the leaflets; 2) temperature difference
etween the leaflets and the ascending aortic wall; and 3) a
ossible correlation between heat production, inflammation,
nd neoangiogenesis.
ethods
tudy population. We examined 96 leaflets scheduled for
ortic valve replacement. Twenty-five patients had AVS,
nd 7 had aortic valve insufficiency (AVI) (control group).
atients with known coronary artery disease, ejection frac-
ion 50%, rheumatic fever in their medical history, inter-
urrent inflammatory or neoplastic condition, or those
edicated with anti-inflammatory drugs except for aspirin
ere excluded from the study. Cardiac catheterization was
erformed to exclude the presence of coronary artery disease
stenoses 50%). The Ethics Committee of all institutions
pproved the study protocol.
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August 26, 2008:758–63 Aortic Valve Thermography in AVSrocedure. After cardiopulmonary bypass was started, the
scending aorta was cross-clamped. Temperature mea-
urements were obtained at this stage (see temperature
easurements in the following text) right before the
ypothermical cardioplegia.
n vivo measurements. A thermographic catheter with a
ensitive thermistor at the distal tip was used (BetaTHERM
ensor, Galway, Ireland). After preparation of the field for
lear visualization of the valve leaflets and exclusion of
acroscopically atherosclerotic lesions on the aortic wall,
he thermistor was placed on each leaflet 5 times, and the
aximal, minimal, and mean temperature was obtained.
he thermistor was applied on the internal aortic wall 5
imes, and the average temperature was assigned as the
ortic wall temperature. “Thermal heterogeneity” within the
eaflets was assigned as the maximal temperature between
he leaflets minus the minimal temperature between the
eaflets.
“Temperature difference” (T) was assigned as the mean
emperature of each leaflet minus the mean temperature of
he aortic wall. “Maximal T” was assigned as the maximal
emperature between the leaflets minus the temperature of
he aortic wall. Aortic valves were then harvested.
x vivo measurements. In 10 additional valves of patients
ith AVS, ex vivo temperature measurements were per-
ormed, immediately after extraction, in a humidified incu-
ator (SANYO, Osaka, Japan) at 37°C in normoxic
onditions.
istological and immunohistochemical analysis. All
amples were fixed in 10% buffered formalin for 24 h,
ecalcified overnight with formic acid, and processed for
outine paraffin embedding. Each leaflet was then divided
adially, and 5-m-thick sections were obtained from
araffin-embedded samples and stained with hematoxylin-
osin staining (3). Histological sections were analyzed
emiquantitatively as previously described (5,8,9).
aseline Demographic and Clinical Characteristics
Table 1 Baseline Demographic and Clinical Characteristics
AVS AVI p Value
Clinical variables
Age, yrs (mean  SD) 68.2 10.52 59.14 13.52 0.06
Male gender 18 (72%) 5 (71.4%) 0.99
Hypertension 16 (64.0%) 4 (57.1%) 0.99
Hyperlipidemia 8 (32.0%) 3 (42.8%) 0.67
Diabetes mellitus 6 (24%) 2 (28.5%) 0.99
Smoking status 8 (32.0%) 3 (42.8%) 0.67
EF (%) 59.04 6.68 59.57 4.61 0.84
Previous medication
ACE-Is 17 (68.0%) 4 (57.1%) 0.67
Statins 8 (32.0%) 3 (42.0%) 0.67
Calcium-channel blockers 6 (24.0%) 3 (42.0%) 0.37
Beta-blockers 6 (24.0%) 2 (28.5%) 0.99
Diuretics 6 (24.0%) 1 (14.3%) 0.99CE-I  angiotensin-converting enzyme inhibitor; AVI  aortic valve insufficiency; AVS  aortic
alve stenosis; EF  ejection fraction. Immunohistochemical stain-
ng for cluster of differentiation 3
CD3), tumor necrosis factor
TNF)-, interleukin (IL)-6,
nd vascular endothelial growth
actor (VEGF) was performed by
tandard immunohistochemistry
ncluding antigen retrieval. The
ollowing primary antibodies
ere used: anti CD3, (Dako,
lostrup, Denmark), anti-TNF-,
RnD, Minneapolis, Minnesota),
nti–IL-6, (RnD), anti-VEGF,
Becton Dickinson, Franklin
akes, New Jersey). For negative
ontrols, the primary antibody
as omitted and replaced by
onimmune serum. Finally, slides were counterstained with
ematoxylin and mounted.
Evaluation of hematoxylin-eosin staining and immuno-
istochemistry was performed independently and blindly on
he groups included by 2 pathologists. For the evaluation of
mmunohistochemistry, CD3 staining was graded according
o the degree of inflammation. The expression of TNF-
nd IL-6 was graded according to previous studies (10). The
EGF quantification was performed semiquantitatively as
reviously described (11).
tatistical analysis. Statistical analysis was performed with
he commercially available software (SPSS Inc., Chicago,
llinois). Quantitative data are presented as rates or mean
alue SD. Probability values are 2-sided from the Student
test for continuous variables. Noncontinuous values were
ompared by the chi-square test. For all histological and
mmunohistological measurements, interobserver and in-
raobserver variability was assessed by reanalysis of a repre-
entative sample of histological sections. A value of p 0.05
as considered significant.
esults
aseline demographic and clinical characteristics. The
rocedure was safe and without complications. The baseline
linical and demographic characteristics are demonstrated in
able 1.
hermographic findings. IN VIVO MEASUREMENTS. Sig-
ificant thermal heterogeneity was recorded in the AVS
ompared with the AVI group. Mean and maximal T was
reater in the AVS compared with the AVI group (Table 2).
n Vivo T of Aortic ValvesPatients With AVS nd AVI
Table 2 In Vivo T of Aortic Valvesin Patients With AVS and AVI
Thermal Heterogeneity Mean T Maximal T
AVS (°C) 1.52 1.35 1.28 0.93 1.96 1.16
AVI (°C) 0.13 0.11 0.06 0.15 0.13 0.13
p value 0.01 0.01 0.01
Abbreviations
and Acronyms
AVI  aortic valve
insufficiency
AVS  aortic valve
stenosis
CD3  cluster of
differentiation 3
IL  interleukin
TNF  tumor necrosis
factor
VEGF  vascular
endothelial growth factor
T  temperature
differenceT  temperature difference; other abbreviations as in Table 1.
I
(
1
0
i
A
n
E
a
1
H
i
t
g
t
t
a
i
9
I
w
(
I
p
I
*
760 Toutouzas et al. JACC Vol. 52, No. 9, 2008
Aortic Valve Thermography in AVS August 26, 2008:758–63n AVS leaflets, T was greater compared with the AVI group
noncoronary: 1.09 1.16°C vs. 0.10 0.10°C; right: 1.24
.03°C vs. 0.02  0.19°C; left: 1.53  1.23°C vs. 0.05 
.19°C; p 0.01 for all comparisons). There was no difference
Figure 1 Representative Photomicrographs of HE
Staining in Examined Specimens of Aortic Valves
(A) Hematoxylin and eosin (HE) staining in aortic valve stenosis showing
intense inflammation (200). (B) The HE staining in aortic valve insufficiency
showing normal valvular stroma with sparse cellularity (200).
mmunohistological Analysis of Aortic Valve Leaflets Between the 2
Table 3 Immunohistological Analysis of Aortic Valve Leaflets B
Grade
AVS (n  75)
0 1 2
Histological features, n (%)
T lymphocytes 0 (0%) 2 (2.6%) 9 (12%)
Mast cells 0 (0%) 0 (0%) 10 (14%)
Calcium deposits 0 (0%) 0 (0%) 2 (3%)
Immunohistological features, n (%)
CD3 0 (0%) 1 (1.3%) 8 (10.6%
TNF- 0 (0%) 2 (2.7%) 12 (16%)
IL-6 0 (0%) 2 (0%) 13 (17.3%p  0.05 for comparisons between aortic valve stenosis (AVS) and aortic valve insufficiency (AVI).
CD3  cluster of differentiation 3; IL  interleukin; TNF  tumor necrosis factor.n T between the 3 leaflets in both groups (AVS: p  0.67,
VI: p 0.72). When analyzed by statin intake, mean T did
ot differ between the 2 groups (p  0.49).
X VIVO MEASUREMENTS. Thermal heterogeneity before
nd after excision was not significant (1.15  0.75°C vs.
.07  0.73°C, p  0.40).
istological analysis. There was no significant difference
n the interobserver and intraobserver readings. Inflamma-
ory infiltrates were present in all samples, in small aggre-
ate areas around substantial calcium deposits or diffused
hroughout the leaflets, on the aortic or ventricular side of
he subendothelial layers. The T-lymphocytes, monocytes,
nd plasma cells were the most predominant cells in these
nfiltrates. Dense lymphocyte infiltration was observed in
7.8% of AVS versus 0% of AVI (p  0.01) (Fig. 1).
ncreased infiltration from mast cells and calcium deposit
as detected in all leaflets from AVS versus none from AVI
p  0.01) (Table 3).
mmunohistochemistry. All specimens from AVS were
ositive for CD3-, TNF-, and IL-6, in contrast to
Figure 2 Representative Photomicrograph of CD3-Positive
Leukocytes in Examined Specimens of Aortic Valves
Intense expression of cluster of differentiation 3 (CD3)–positive leukocytes in
aortic valve stenosis.
ups of Patients
en the 2 Groups of Patients
AVI (n  21)
3 0 1 2 3
64 (85.4%) 19 (90.4%)* 2 (9.6%) 0 (0%)* 0 (0%)*
65 (86%) 17 (81%)* 4 (9%)* 0 (0%)* 0 (0%)*
73 (97%) 16 (76%)* 5 (23%)* 0 (0%) 0 (0%)*
66 (88%) 17 (80.9%)* 4 (19.0%)* 0 (0%) 0 (0%)*
61 (81.3%) 16 (76.2%)* 5 (23.8%)* 0 (0%)* 0 (0%)*
60 (80%) 17 (80.9%)* 4 (19.0%)* 0 (0%)* 0 (0%)*Gro
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August 26, 2008:758–63 Aortic Valve Thermography in AVSegative specimens of the AVI group (Figs. 2 to 4). Intense
xpression of inflammatory indexes was found in the AVS
ompared with the AVI group (Table 3). We categorized
pecimens into 2 groups with a cut-off value of 2 on the
asis of the semiquantitative scale for CD3, TNF-, IL-6,
alcium deposit, mast cell, and T lymphocyte expression.
ean T was greater in leaflets with intense compared with
ow expression of CD3, TNF-, and IL-6 (CD-3: 1.26 
.11°C vs. 0.51  1.01°C; TNF-: 1.38  1.13°C vs.
.39  0.83°C; IL-6: 1.35  1.12°C vs. 0.49  0.95°C,
 0.01 for all comparisons) (Figs. 5A to 5C).
Mean T was greater in leaflets with intense compared
ith low expression of calcium deposit (1.33  1.11°C vs.
.02  0.25°C, p  0.01). In leaflets with AVS and intense
xpression of mast cells, mean T was greater compared
ith leaflets with low expression (1.52  1.01°C vs. 0.26 
.67°C, p  0.01). In leaflets with AVS and intense
xpression of T lymphocytes, mean T was greater com-
Figure 3 Representative Photomicrographs of Anti–TNF-
Staining in Examined Specimens of Aortic Valves
(A) Anti–tumor necrosis factor (TNF)- staining in aortic valve stenosis. Arrows
indicate positivity to anti–TNF-. (B) Anti–TNF- staining in aortic valve insuffi-
ciency showing negative staining for anti–TNF- (400).Wared with leaflets with low expression (0.54  1.00°C vs.
.21  0.66°C, p  0.01).
EGF immunoreactivity. Neoangiogenesis was evident in
ll AVS specimens, in areas where inflammatory infiltrates
ere denser, in contrast to AVI (Fig. 6, Table 4). Mean T
as greater in leaflets with a high compared with a low
egree of VEGF immunoreactivity (1.28  1.14°C vs.
.18  0.38°C, p  0.01) (Fig. 5D).
iscussion
he main finding of this study is that nonrheumatic aortic
tenotic valves have in vivo significant thermal heterogeneity
hat correlates with inflammatory infiltrates and neovessels,
upporting the hypothesis that an active inflammatory
rocess is involved.
Calcific aortic valve disease has been recognized as an
ctive process with features of chronic inflammation (12).
Figure 4 Representative Photomicrographs of IL-6
Staining in Examined Specimens of Aortic Valves
(A) Interleukin (IL)-6 staining in aortic valve stenosis. Arrows indicate IL-6
immunopositive inflammatory cells in the valve stroma (400). (B). The IL-6
staining in aortic insufficiency showing negative staining for IL-6 (400).e therefore evaluated local inflammatory process at the
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Aortic Valve Thermography in AVS August 26, 2008:758–63eaflets of AVS by thermography, because it is the only
ethod currently available to measure heat generation
eflecting inflammation (13,14). According to our results
here is a significant difference in local inflammatory acti-
ation within aortic valve leaflets as well as between the
eaflets of the same stenotic valve. This difference was
ssociated with increased inflammatory cell infiltration, such
s T-lymphocytes and mast cells, in accordance with previ-
us observations (15). Other studies have shown that
ncreased inflammatory markers are attributed to shared risk
actors with cardiovascular disease and infiltration of li-
oproteins and interstitial cells (16,17). Inhibition of the
nflammatory activation, possibly by statins (18,19) al-
hough not demonstrated in the current study, might be a
eneficial pharmacological prevention of AVS.
tudy limitations. We performed ex vivo measurements
rom AVS specimens to verify that temperature measure-
ents were not altered right before hypothermical cardio-
legia. In vivo measurements during cardiac catheterization
ould be the ideal method; however, the impact of the cooling
ffect of blood flow on thermography could not have been
liminated (20). Furthermore, we used as a reference temper-
ture the temperature of the aortic wall. Although we mac-
oscopically selected areas without atherosclerotic lesions,
e cannot exclude the presence of small lesions with
nflammatory activation, leading to underestimation of the
emperature difference between the aortic wall and aortic
alve. In addition, further subgroup analysis is limited by the
Figure 5 DT in Leaflets With Intense Versus Low Expression of
Mean temperature difference (DT) in leaflets with intense versus leaflets with low
(VEGF) (D). The bottom of the boxes represents the first quartile; the top of the b
value. Abbreviations as in Figures 2, 3, and 4.mall number of stenotic aortic valves with low inflamma-
*ory activation. Finally, patients with AVI comprised the
ontrol group, because “normal” heart valves cannot be used.
linical implications. The present study supports the
ypothesis that an active inflammatory process is involved in
VS. Anti-inflammatory treatment and statin intake in
uch patients might have significant prognostic and thera-
eutic implications. Future studies need to be performed for
urther evaluation.
onclusions
onrheumatic aortic stenotic valves have in vivo significant
hermal heterogeneity reflecting an active local inflamma-
ory activation. Neoangiogenesis, local inflammatory activa-
ion, and thermal heterogeneity are increased in AVS.
urther studies need to be performed to investigate whether
revention of neoangiogenesis might have significant prog-
ostic and therapeutic implications.
mmatory Indexes
sion of CD3 (A), TNF- (B), IL-6 (C), and vascular endothelial growth factor
epresents the third quartile, and the line in the box represents the median
emiquantitative VEGF Immunoreactivity Betweenaflets of Patients With AVS and Pat ents With AVI
Table 4 Semiquantitative VEGF Immunoreactivity BetweenLeaflets of Patients With AVS and Patients With AVI
AVS (n  75) AVI (n  21)
0 (0%) 16 (76.2%)*
 0 (0%) 5 (23.8%)*
 4 (5.3%) 0 (0%)*
 6 (8.0%) 0 (0%)*
 65 (86.6%) 0 (0%)*Infla
expres
oxes rp 0.05 for comparisons between aortic valve stenosis (AVS) and aortic valve insufficiency (AVI).
VEGF  vascular endothelial growth factor.
R
t
G
R
1
1
1
1
1
1
1
1
1
1
2
763JACC Vol. 52, No. 9, 2008 Toutouzas et al.
August 26, 2008:758–63 Aortic Valve Thermography in AVSeprint requests and correspondence: Dr. Konstantinos Tou-
ouzas, 26 Karaoli and Dimitriou Street, Holargos, 15562 Athens,
reece. E-mail: ktoutouz@otenet.gr.
EFERENCES
1. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O’Brien KD.
Characterization of the early lesion of ‘degenerative’ valvular aortic
stenosis. Histological and immunohistochemical studies. Circulation
1994;90:844–53.
2. Olsson M, Dalsgaard CJ, Haegerstrand A, Rosenqvist M, Ryden L,
Figure 6 Representative Photomicrographs of VEGF
Staining in Examined Specimens of Aortic Valves
(A) Marked vascular endothelial growth factor (VEGF) immunoreactivity in
neovessels in severe aortic stenosis (400). (B) Aortic valve insufficiency
showing no VEGF immunoreactivity (400).Nilsson J. Accumulation of T lymphocytes and expression of Kinterleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am
Coll Cardiol 1994;23:1162–70.
3. Mazzone A, Epistolato MC, De Caterina R, et al. Neoangiogenesis,
T-lymphocyte infiltration, and heat shock protein-60 are biological
hallmarks of an immunomediated inflammatory process in end-stage
calcified aortic valve stenosis. J Am Coll Cardiol 2004;43:1670–6.
4. Chandra HR, Goldstein JA, Choudhary N, et al. Adverse outcome in
aortic sclerosis is associated with coronary artery disease and inflam-
mation. J Am Coll Cardiol 2004;43:169–75.
5. Mazzone A, Epistolato MC, Gianetti J, et al. Biological features
(inflammation and neoangiogenesis) and atherosclerotic risk factors in
carotid plaques and calcified aortic valve stenosis: two different sites of
the same disease? Am J Clin Pathol 2006;126:494–502.
6. Stefanadis C, Diamantopoulos L, Vlachopoulos C, et al. Thermal
heterogeneity within human atherosclerotic coronary arteries detected
in vivo: a new method of detection by application of a special
thermography catheter. Circulation 1999;99:1965–71.
7. Verheye S, Kockx MM, Casscells SW. Thermography to detect
inflamed macrophage-rich plaques. Circulation 2003;107:e212–3, au-
thor reply e212–3.
8. Wallby L, Janerot-Sjoberg B, Steffensen T, Broqvist M. T lymphocyte
infiltration in nonrheumatic aortic stenosis: a comparative descriptive
study between tricuspid and bicuspid aortic valves. Heart 2002;88:
348–51.
9. Warren BA, Yong JL. Calcification of the aortic valve: its progression
and grading. Pathology 1997;29:360–8.
0. Guilherme L, Cury P, Demarchi LM, et al. Rheumatic heart disease:
proinflammatory cytokines play a role in the progression and mainte-
nance of valvular lesions. Am J Pathol 2004;165:1583–91.
1. Stefanadis C, Toutouzas K, Stefanadi E, Lazaris A, Patsouris E,
Kipshidze N. Inhibition of plaque neovascularization and intimal
hyperplasia by specific targeting vascular endothelial growth factor
with bevacizumab-eluting stent: an experimental study. Atherosclero-
sis 2007;195:269–76.
2. O’Brien KD. Pathogenesis of calcific aortic valve disease: a disease
process comes of age (and a good deal more). Arterioscler Thromb
Vasc Biol 2006;26:1721–8.
3. Stefanadis C, Chrysochoou C, Markou D, et al. Increased temperature
of malignant urinary bladder tumors in vivo: the application of a new
method based on a catheter technique. J Clin Oncol 2001;19:676–81.
4. Casscells W, Hathorn B, David M, et al. Thermal detection of cellular
infiltrates in living atherosclerotic plaques: possible implications for
plaque rupture and thrombosis. Lancet 1996;347:1447–51.
5. Helske S, Syvaranta S, Kupari M, et al. Possible role for mast
cell-derived cathepsin G in the adverse remodelling of stenotic aortic
valves. Eur Heart J 2006;27:1495–504.
6. Fox CS, Guo CY, Larson MG, et al. Relations of inflammation and
novel risk factors to valvular calcification. Am J Cardiol 2006;97:
1502–5.
7. Agmon Y, Khandheria BK, Jamil Tajik A, et al. Inflammation,
infection, and aortic valve sclerosis; Insights from the Olmsted County
(Minnesota) population. Atherosclerosis 2004;174:337–42.
8. Osman L, Yacoub MH, Latif N, Amrani M, Chester AH. Role of
human valve interstitial cells in valve calcification and their response to
atorvastatin. Circulation 2006;114:I547–52.
9. Osman L, Chester AH, Amrani M, Yacoub MH, Smolenski RT. A
novel role of extracellular nucleotides in valve calcification: a potential
target for atorvastatin. Circulation 2006;114:I566–72.
0. Stefanadis C, Toutouzas K, Tsiamis E, et al. Thermal heterogeneity in
stable human coronary atherosclerotic plaques is underestimated
in vivo: the “cooling effect” of blood flow. J Am Coll Cardiol
2003;41:403–8.ey Words: aortic valve y inflammation thermography.
